CFDE Data Portal | Search LOC124902825

	Label	Description
	LOC124902825 Gene (Entity type)	ENSG00000238724 - small nucleolar RNA U13
	GSE205714 GSE229013 adenosine 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE147876 GSE147877 enzalutamide MR42D 4 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119424 GSE120214 TBXT brachyury inhibition 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 0 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202744 CDK9 inhibition Toyocamycin 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE140768 BMI1 inhibition 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE249569 NCAPD3 knockdown 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE183741 GSE183806 POU2F2 POU2AF1 knockdown UtE-iPS-1 6 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

LOC124902825

ENSG00000238724 - small nucleolar RNA U13

GSE205714 GSE229013 adenosine 3 v 2 human up

A Gene Set from LINCS

GSE147876 GSE147877 enzalutamide MR42D 4 v 7 human up

A Gene Set from LINCS

GSE119424 GSE120214 TBXT brachyury inhibition 1 v 3 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 0 v 5 human up

A Gene Set from LINCS

GSE202744 CDK9 inhibition Toyocamycin 1 v 3 human up

A Gene Set from LINCS

GSE140768 BMI1 inhibition 0 v 1 human dn

A Gene Set from LINCS

GSE249569 NCAPD3 knockdown 1 v 0 human dn

A Gene Set from LINCS

GSE183741 GSE183806 POU2F2 POU2AF1 knockdown UtE-iPS-1 6 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.